Besides M30, other Fe chelators including desferrioxamine (DFO; the standard clinically used Fe chelator for Fe overload) have also been shown to induce VEGF expression in non-ALS models (Beerepoot et al., 1996). Here, VEGFA is linked to amyotrophic lateral sclerosis.